Cytosorbents Corp.

CTSONASDAQUSD
0.50 USD
0.04 (8.16%)AT CLOSE (11:59 AM EDT)
0.50
0.00 (0.48%)
POST MARKET (AS OF 07:11 PM EDT)
Post Market
AS OF 07:11 PM EDT
0.50
0.00 (0.48%)
🔴Market: CLOSED
Open?$0.53
High?$0.55
Low?$0.49
Prev. Close?$0.54
Volume?190.0K
Avg. Volume?70.5K
VWAP?$0.52
Rel. Volume?2.69x
Bid / Ask
Bid?$0.45 × 1.3K
Ask?$0.51 × 5.0K
Spread?$0.06
Midpoint?$0.48
Valuation & Ratios
Market Cap?31.4M
Shares Out?62.7M
Float?55.2M
Float %?87.8%
P/E Ratio?N/A
P/B Ratio?14.31
EPS?-$0.19
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.
Employees
129
Market Cap
31.2M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2005-05-17
Address
305 COLLEGE ROAD EAST
PRINCETON, NJ 08540
Phone: 973-329-8885
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.09Adequate
Quick Ratio?0.81Weak
Cash Ratio?0.30Low
Debt/Equity?7.73High
ValuationATTRACTIVELY VALUED
Score
83/100
P/E?
N/A
P/B?
14.31HIGH
P/S?
0.84CHEAP
P/FCF?
N/A
EV/EBITDA?
-3.7CHEAP
EV/Sales?
1.17CHEAP
Returns & Efficiency
ROE?
-540.1%WEAK
ROA?
-29.2%WEAK
Cash Flow & Enterprise
FCF?$-10246924
Enterprise Value?$43.5M
Fundamentals ratios updated end of day